Jafron Biomedical Co.,Ltd.
SHZ: 300529.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Fan Dong
- Employees
- 2,797
- Headquarters
- Zhuhai, China
- IPO year
- 2016
- Market cap
- CN¥15.1B
- Website
- https://www.jafron.com
Loading 300529…
Loading profile data…Frequently asked questions about 300529
What does Jafron Biomedical Co.,Ltd. (300529.SZ) do?
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous...
Where does 300529.SZ trade?
Jafron Biomedical Co.,Ltd. (300529.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300529.SZ in?
Jafron Biomedical Co.,Ltd. (300529.SZ) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Jafron Biomedical Co.,Ltd.?
Fan Dong is the chief executive officer of Jafron Biomedical Co.,Ltd. (300529.SZ).
Where is Jafron Biomedical Co.,Ltd. headquartered?
Jafron Biomedical Co.,Ltd. is headquartered in China.
Does 300529.SZ pay a dividend?
Yes — Jafron Biomedical Co.,Ltd. (300529.SZ) paid a trailing twelve-month dividend of CNY 0.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300529.SZ go public?
Jafron Biomedical Co.,Ltd. (300529.SZ) completed its initial public offering in 2016.